Eli Lilly releases single-dose vials of Zepbound at half the price of other obesity meds

Eli Lilly will begin selling single-dose vials of its drug tirzepatide, marketed as Zepbound for weight loss, and price them at least 50% lower than …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Generic Fluticasone–Salmeterol Inhaler for COPD Matches Branded Product

A generic fluticasone-salmeterol (Wixela Inhub) maintenance inhaler was clinically equivalent to name-brand Advair Diskus for chronic obstructive pulmonary disease (COPD), a propensity score-matched cohort study

August 8, 2023

(Curcumin + doxorubicin) by Immix BioPharma for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 24, 2023

Bayer and Aignostics to collaborate on next generation precision oncology – Biotech Investments

EQS-News: Aignostics GmbH / Key word(s): Alliance Bayer and Aignostics to collaborate on next generation precision oncology 14.03.2024 / 08:30 CET/CEST The issuer is solely

March 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.